A new trading day began on Monday, with Agilon Health Inc (NYSE: AGL) stock price up 19.58% from the previous day of trading, before settling in for the closing price of $1.89. AGL’s price has ranged from $1.50 to $13.76 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 53.71% over the last five years. Meanwhile, its annual earnings per share averaged -15.83%. With a float of $303.27 million, this company’s outstanding shares have now reached $406.39 million.
The firm has a total of 1117 workers. Let’s measure their productivity. In terms of profitability, gross margin is -1.22%, operating margin of -6.17%, and the pretax margin is -5.56%.
Agilon Health Inc (AGL) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Care Facilities Industry. The insider ownership of Agilon Health Inc is 26.39%, while institutional ownership is 80.54%. The most recent insider transaction that took place on Sep 12 ’24, was worth 67,188. In this transaction CEO & President of this company bought 20,000 shares at a rate of $3.36, taking the stock ownership to the 67,590 shares. Before that another transaction happened on Nov 29 ’23, when Company’s Director bought 22,300 for $11.22, making the entire transaction worth $250,206. This insider now owns 31,931 shares in total.
Agilon Health Inc (AGL) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.41 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -15.83% per share during the next fiscal year.
Agilon Health Inc (NYSE: AGL) Trading Performance Indicators
Here are Agilon Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -0.33 in one year’s time.
Technical Analysis of Agilon Health Inc (AGL)
Analysing the last 5-days average volume posted by the [Agilon Health Inc, AGL], we can find that recorded value of 4.11 million was lower than the volume posted last year of 4.95 million. As of the previous 9 days, the stock’s Stochastic %D was 63.57%. Additionally, its Average True Range was 0.25.
During the past 100 days, Agilon Health Inc’s (AGL) raw stochastic average was set at 12.20%, which indicates a significant decrease from 45.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 223.77% in the past 14 days, which was higher than the 112.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.8600, while its 200-day Moving Average is $4.9700. Now, the first resistance to watch is $2.4000. This is followed by the second major resistance level at $2.5400. The third major resistance level sits at $2.7800. If the price goes on to break the first support level at $2.0200, it is likely to go to the next support level at $1.7800. Should the price break the second support level, the third support level stands at $1.6400.
Agilon Health Inc (NYSE: AGL) Key Stats
With a market capitalization of 988.70 million, the company has a total of 412,018K Shares Outstanding. Currently, annual sales are 4,316 M while annual income is -262,600 K. The company’s previous quarter sales were 1,451 M while its latest quarter income was -117,620 K.
